Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 7.19B | 7.14B | 6.88B | 5.65B | 3.27B | 3.18B |
Gross Profit | 3.91B | 3.85B | 3.62B | 3.10B | 1.73B | 1.61B |
EBITDA | 3.75B | 3.96B | 1.87B | 4.36B | 1.46B | -202.00M |
Net Income | 1.36B | 1.69B | -585.00M | 4.22B | 610.00M | -1.41B |
Balance Sheet | ||||||
Total Assets | 81.60B | 80.69B | 73.21B | 75.22B | 66.80B | 64.81B |
Cash, Cash Equivalents and Short-Term Investments | 2.22B | 1.29B | 769.00M | 1.63B | 1.59B | 2.62B |
Total Debt | 40.88B | 38.70B | 35.63B | 37.09B | 35.66B | 34.38B |
Total Liabilities | 48.88B | 46.99B | 43.48B | 44.28B | 41.38B | 40.73B |
Stockholders Equity | 32.54B | 33.53B | 29.57B | 30.73B | 25.21B | 23.88B |
Cash Flow | ||||||
Free Cash Flow | -2.27B | 802.00M | 1.27B | 1.04B | -479.00M | -644.00M |
Operating Cash Flow | 1.92B | 1.83B | 2.19B | 2.38B | 430.00M | 460.00M |
Investing Cash Flow | -6.49B | -4.12B | -1.48B | -1.64B | -1.52B | -1.60B |
Financing Cash Flow | 5.90B | 2.70B | -1.70B | -806.00M | 93.00M | 3.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | kr27.76B | 14.68 | 8.38% | 3.54% | 5.54% | 4011.70% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | kr34.68B | 25.65 | 4.29% | 2.40% | 1.21% | 158.02% | |
64 Neutral | €18.88B | 26.49 | 29.21% | 4.30% | 0.01% | 17.20% | |
63 Neutral | kr19.63B | 27.54 | 3.82% | 2.33% | -1.62% | 1577.54% | |
57 Neutral | kr23.78B | 25.18 | 3.50% | 2.30% | 6.42% | ― | |
52 Neutral | kr24.07B | 119.72 | 0.53% | 2.54% | -4.31% | ― |
Pandox AB has announced the formation of its nomination committee for the 2026 annual general meeting, consisting of representatives from its largest shareholders and the chairman of the board. This committee is responsible for proposing the composition of the board, with the proposals to be presented in the notice for the AGM scheduled for April 2026. This move is in line with the principles adopted at the 2025 AGM and reflects Pandox’s commitment to structured governance and stakeholder engagement.
The most recent analyst rating on ($SE:PNDX.B) stock is a Hold with a SEK180.00 price target. To see the full list of analyst forecasts on Pandox AB stock, see the SE:PNDX.B Stock Forecast page.
Pandox AB, in collaboration with Eiendomsspar AS, has announced a cash offer to acquire Dalata Hotel Group plc, valuing the company at approximately MEUR 1,400. This acquisition, which is fully financed, will expand Pandox’s footprint in several dynamic hotel markets and deepen their partnership with Scandic Hotels Group. The acquisition includes 56 hotel businesses across Ireland, the UK, Germany, and the Netherlands. Post-acquisition, there are plans to separate Dalata’s real estate and hotel operations, with Scandic potentially acquiring the hotel operating business. This strategic move is expected to enhance Pandox’s property value and operational scope.
The most recent analyst rating on ($SE:PNDX.B) stock is a Buy with a SEK223.00 price target. To see the full list of analyst forecasts on Pandox AB stock, see the SE:PNDX.B Stock Forecast page.
Pandox AB is set to release its interim report for the first half of 2025 on July 11, followed by a webcasted telephone conference. The event will feature presentations on market data for the international and Nordic hotel markets by independent experts. This announcement is part of Pandox’s ongoing efforts to provide transparency and insights into its operations, potentially impacting its stakeholders by offering a clearer view of market trends and company performance.
The most recent analyst rating on ($SE:PNDX.B) stock is a Buy with a SEK214.00 price target. To see the full list of analyst forecasts on Pandox AB stock, see the SE:PNDX.B Stock Forecast page.